GE Healthcare Technologies Inc (GEHC) shares surged 5.01% in pre-market trading on Wednesday following the release of its first-quarter 2025 financial results, which exceeded analysts' expectations. The medical device maker reported adjusted earnings per share of $1.01, surpassing the consensus estimate of $0.91, and revenue of $4.8 billion, beating the forecast of $4.663 billion.

Adding to the positive sentiment, GE Healthcare's board of directors authorized a $1 billion share repurchase program, signaling confidence in the company's financial position and commitment to delivering shareholder value. The company also reported strong customer demand in many of its served markets, further boosting investor optimism.

However, the pre-market rally comes despite GE Healthcare cutting its full-year 2025 profit forecast. The company now expects adjusted earnings per share in the range of $3.90 to $4.10, down from the previous guidance of $4.61 to $4.75. This reduction is primarily attributed to the anticipated impact of escalating global trade tensions and tariffs, particularly those affecting U.S.-China trade relations. Despite this headwind, investors appear to be focusing on the company's strong current performance and positive capital allocation decisions.